Rabbit Anti-Human DLD Polyclonal Antibody Knockout Validated

This paper describes the behavior of particles in a deterministic lateral displacement (DLD) separation device with DC and AC electric fields applied orthogonal to the fluid flow. As proof of principle, we demonstrate tunable microparticle and nanoparticle separation and fractionation depending on both particle size and zeta potential. DLD is a microfluidic technique that performs size-based binary separation of particles in a continuous flow. Here, we explore how the application of both DC and AC electric fields (separate or together) can be used to improve separation in a DLD device. We show that particles significantly smaller than the critical diameter of the device can be efficiently separated by applying orthogonal electric fields. Following the application of a DC voltage, Faradaic processes at the electrodes cause local changes in medium conductivity. This conductivity change creates an electric field gradient across the channel that results in a nonuniform electrophoretic velocity orthogonal to the primary flow direction. This phenomenon causes particles to focus on tight bands as they flow along the channel countering the effect of particle diffusion. It is shown that the final lateral displacement of particles depends on both particle size and zeta potential. Experiments with six different types of negatively charged particles and five different sizes (from 100nm to 3 mu m) and different zeta potential demonstrate how a DC electric field combined with AC electric fields (that causes negative-dielectrophoresis particle deviation) could be used for fractionation of particles on the nanoscale in microscale devices.

Although oxaliplatin is an effective chemotherapeutic drug for colorectal cancer (CRC) treatment, patients often develop resistance to it. Therefore, a new strategy for CRC treatment is needed. The purpose of this study was to determine the effect of cannabidiol (CBD), one of the components of the cannabis plant, in overcoming oxaliplatin resistance in CRC cells. We established oxaliplatin-resistant cell lines, DLD-1 R and colo205 R, in CRC DLD-1 and colo205 cells. Autophagic cell death was induced when oxaliplatin-resistant cells were treated with both oxaliplatin and CBD. Additionally, phosphorylation of nitric oxide synthase 3 (NOS3) was increased in oxaliplatin-resistant cells compared to that in parent cells. Combined treatment with oxaliplatin and CBD reduced phospho-NOS3 levels and nitric oxide (NO) production and resulted in the production of reactive oxygen species (ROS) by reducing the levels of superoxide dismutase 2, an antioxidant present in the mitochondria, causing mitochondrial dysfunction. Taken together, these results suggest that elevated phosphorylation of NOS3 is essential for oxaliplatin resistance. The combination of oxaliplatin and CBD decreased NOS3 phosphorylation, which resulted in autophagy, by inducing the overproduction of ROS through mitochondrial dysfunction, thus overcoming oxaliplatin resistance.